Researchers use acetyl glycoproteina (GlycA) to predict diseases associated with chronic inflammation
Group of International Scientists recently published in Circulation: Genomic and Precision Medicine, his findings on the relationship between chronic inflammation and the development of diseases. Using the methodology Nightingale to track glycoprotein acetyls (GlycA), Biomarkers of chronic inflammation, researchers found that an increase in GlycA levels was associated with many internal organ diseases, such as renal failure, heart failure and liver and heart diseases. In addition, by measuring the levels of GlycA, It was possible to identify among the study group (11,861 volunteers), those who had a five times higher mortality risk, related to cardiovascular diseases. Revealing the great potential that has GlycA as a marker of chronic inflammation and predictor of disease.